A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.
about
Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid DependenceBaseline characteristics of patients predicting suitability for rapid naltrexone induction.The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.Memantine improves buprenorphine/naloxone treatment for opioid dependent young adultsTherapies in early development for the treatment of opiate addiction.Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study.A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement.Extended-release injectable naltrexone for opioid use disorder: A systematic review.Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
P2860
Q35751878-EA59F274-E241-428E-9DAF-A49DD8827F1AQ35834292-67E6EF98-F904-4C82-BFD0-596BEF17B1CAQ35952033-0C904D70-3E4A-4160-B155-6D56D91C780DQ36297525-509ED7D8-368E-454D-97A4-06DD850E62DAQ38594606-802D2611-191D-446B-84B8-65E479AFE809Q38761584-4A9BBB0E-55DC-457E-AABC-7B2BE411AC43Q43061611-9DA6CCFA-C093-44B2-B551-6DCB523A5BB8Q44342511-3ECE244E-C9EA-4481-BF7F-8952AD0FF0A1Q44344766-DEF25BD4-C0D0-4C84-BE5D-F963A6F3C723Q48111086-E416D470-E38B-41ED-BD95-7AD3AC4FFB2FQ52311312-BF74723B-7647-4706-9BE9-BCD82A7D368DQ52317035-DC2A0351-1829-4D60-9251-B7CD38F4D428Q53621004-193BA85E-3C47-4037-A9F1-5491BFC1DEEA
P2860
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A placebo-controlled trial of ...... trexone for opioid dependence.
@ast
A placebo-controlled trial of ...... trexone for opioid dependence.
@en
A placebo-controlled trial of ...... trexone for opioid dependence.
@nl
type
label
A placebo-controlled trial of ...... trexone for opioid dependence.
@ast
A placebo-controlled trial of ...... trexone for opioid dependence.
@en
A placebo-controlled trial of ...... trexone for opioid dependence.
@nl
prefLabel
A placebo-controlled trial of ...... trexone for opioid dependence.
@ast
A placebo-controlled trial of ...... trexone for opioid dependence.
@en
A placebo-controlled trial of ...... trexone for opioid dependence.
@nl
P2093
P2860
P921
P1476
A placebo-controlled trial of ...... trexone for opioid dependence.
@en
P2093
Andrew Glass
Edward V Nunes
Frances R Levin
John J Mariani
Kenneth M Carpenter
Maria A Sullivan
P2860
P304
P356
10.1016/J.JSAT.2014.01.005
P577
2014-01-17T00:00:00Z